Clinical trial
Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15…
NCT00161863 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00161863 |
|---|---|
| Title | Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years |
| Official title | Open-label Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tick-borne Encephalitis |
| Intervention type | Biological |
| Interventions | FSME-IMMUN NEW 0.25 ml |
| Start date | Sep 1, 2002 |
| Completion | Jan 1, 2003 |
| First posted | Sep 13, 2005 |
| Last update posted | May 21, 2015 |
| Countries | Austria, Germany, Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: